Local News

• Johnson & Johnson extends tender offer for Mentor Corporation  Johnson & Johnson announced it has extended its previously announced cash tender offer, through its wholly owned subsidiary, Maple Merger Sub, for all outstanding shares of common stock of Mentor Corporation until 5:00 p.m. (Eastern time), on January 16, 2009, unless further extended.
  Johnson & Johnson January 06, 2009  
• Monsanto announces yield gains with Deltapine Class Of 09  Monsanto Company announced its D&PL business will market five new varieties as the Deltapine Class of 09 for the coming production season. These varieties were introduced during the 2009 Beltwide Cotton Conferences that have brought the cotton industry together in San Antonio.
  Monsanto Company January 06, 2009  
• Study shows Medtronic deep brain stimulation therapy improved quality of life  In the largest published, randomized, controlled study of deep brain stimulation (DBS) for Parkinson's disease, DBS was shown to be more effective than best medical therapy in improving quality of life, periods of good symptom control and motor function in patients with advanced Parkinson's disease.
  Medtronic, Inc. January 06, 2009  
• Court rules in favor of Medtronic in Fidelis litigation  Medtronic reported that on Jan. 5, the U.S. District Court for the District of Minnesota dismissed with prejudice complaints relating to the multi-district litigation (MDL) involving Medtronic's Sprint Fidelis defibrillator leads on grounds of federal preemption.
  Medtronic, Inc. January 06, 2009  
• Abbott completes acquisition of Ibis Biosciences, a subsidiary of Isis  Isis Pharmaceuticals and Abbott announced that Abbott has completed its purchase of Ibis Biosciences, an Isis subsidiary, for a closing purchase price of $175 million.
  Isis Pharmaceuticals, Inc. January 06, 2009  
• MedImmune submits Marketing Authorisation Application in EU for intranasal flu vaccine  MedImmune, the global biologics unit of AstraZeneca, announced that it has submitted a Marketing Authorisation Application (MAA) for its nasal spray live attenuated influenza vaccine (LAIV), which is now being reviewed by the European Medicines Agency (EMEA).
  AstraZeneca January 06, 2009  
• Dick Bond leaving Tyson Foods  Dick Bond, president and chief executive officer of Tyson Foods, announced he is leaving the company, effective immediately. Leland Tollett, former chairman and CEO of the company, has agreed to return to the company as President and CEO on an interim basis.
  Tyson Foods, Inc. January 05, 2009  
• Medtronic announces clinical trial of stent for peripheral arterial disease  Consistent with its commitment to addressing unmet patient needs, Medtronic announced the first enrollment in the company's FDA-approved clinical trial of its self-expanding (SE) Complete SE stent for the treatment of peripheral arterial disease (PAD) in the superficial femoral artery (SFA).
  Medtronic, Inc. January 05, 2009  
• Medtronic launches its first Integrated Power Console Platform for use in spinal surgeries  Medtronic announced the launch of the Integrated Power Console (IPC(TM)) platform, its first multispecialty surgical power console for use in spinal, cranial, and ear, nose, and throat (ENT) surgeries.
  Medtronic, Inc. January 05, 2009  
• PPD enters into strategic collaboration with Merck  PPD announced it has entered into a strategic collaboration with Merck & Co. involving vaccine testing and assay development. Under the agreements, PPD purchased Merck's 130,000 square-foot vaccine testing laboratory and related equipment in Wayne, Penn.
  PPD, Inc. January 05, 2009  

   (next 10 articles)